| Natural history of patients with congenital dysfibrinogenemia A Casini, M Blondon, A Lebreton, J Koegel, V Tintillier, E De Maistre, ... Blood, The Journal of the American Society of Hematology 125 (3), 553-561, 2015 | 185 | 2015 |
| Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis T Sinegre, C Duron, T Lecompte, B Pereira, S Massoulier, G Lamblin, ... Journal of Thrombosis and Haemostasis 16 (6), 1132-1140, 2018 | 86 | 2018 |
| Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination J Douxfils, J Favresse, JM Dogné, T Lecompte, S Susen, C Cordonnier, ... Thrombosis research 203, 163-171, 2021 | 78 | 2021 |
| Prospective evaluation of a rapid nanoparticle‐based lateral flow immunoassay (STic Expert® HIT) for the diagnosis of heparin‐induced thrombocytopenia D Leroux, N Hezard, A Lebreton, A Bauters, P Suchon, E de Maistre, ... British journal of haematology 166 (5), 774-782, 2014 | 56 | 2014 |
| Management of congenital quantitative fibrinogen disorders: a Delphi consensus A Casini, P de Moerloose, Congenital Fibrinogen Disorders Group, ... Haemophilia 22 (6), 898-905, 2016 | 50 | 2016 |
| Thrombin generation and cirrhosis: state of the art and perspectives A Lebreton, T Sinegre, T Lecompte, L Talon, A Abergel, T Lisman Seminars in thrombosis and hemostasis 46 (06), 693-703, 2020 | 42 | 2020 |
| Prevalence and epitope specificity of non-neutralising antibodies in a large cohort of haemophilia A patients without inhibitors A Lebreton, P Lapalud, H Chambost, C Biron-Andreani, PE Morange, ... Thrombosis and haemostasis 105 (06), 954-961, 2011 | 39 | 2011 |
| Comparative analysis of a French prospective series of 144 patients with heparin-induced thrombocytopenia (FRIGTIH) and the literature Y Gruel, C Vayne, J Rollin, P Weber, D Faille, A Bauters, L Macchi, ... Thrombosis and Haemostasis 120 (07), 1096-1107, 2020 | 37 | 2020 |
| Plasma hypercoagulability in the presence of thrombomodulin but not of activated protein C in patients with cirrhosis A Lebreton, T Sinegre, B Pereira, G Lamblin, C Duron, A Abergel Journal of Gastroenterology and Hepatology 32 (4), 916-924, 2017 | 35 | 2017 |
| Hypercoagulability (thrombin generation) in patients with cirrhosis is detected with ST‐Genesia L Talon, T Sinegre, T Lecompte, B Pereira, S Massoulié, A Abergel, ... Journal of Thrombosis and Haemostasis 18 (9), 2177-2190, 2020 | 32 | 2020 |
| Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemia A Charpentier, A Lebreton, A Rauch, A Bauters, N Trillot, O Nibourel, ... Haematologica 101 (9), e365, 2016 | 31 | 2016 |
| Epicatechin influences primary hemostasis, coagulation and fibrinolysis T Sinegre, D Teissandier, D Milenkovic, C Morand, A Lebreton Food & function 10 (11), 7291-7298, 2019 | 27 | 2019 |
| Diagnosis of congenital fibrinogen disorders A Lebreton, A Casini Annales de biologie clinique 74 (4), 405-412, 2016 | 26 | 2016 |
| Successful pregnancy under fibrinogen substitution in a woman with congenital afibrinogenaemia complicated by a postpartum venous thrombosis. A Lebreton, A Casini, R Alhayek, KL Kouteich, M Neerman‐Arbez, ... Haemophilia 21 (1), 2015 | 23 | 2015 |
| Long-term antithrombotic treatments prescribed for cardiovascular diseases in patients with hemophilia: results from the French registry B Guillet, G Cayla, A Lebreton, N Trillot, B Wibaut, C Falaise, S Castet, ... Thrombosis and Haemostasis 121 (03), 287-296, 2021 | 21 | 2021 |
| Use of direct oral anticoagulants in children and adolescents M Albisetti Hämostaseologie 40 (01), 064-073, 2020 | 21 | 2020 |
| Dabigatran level before reversal can predict hemostatic effectiveness of idarucizumab in a real-world setting N Gendron, R Chocron, P Billoir, J Brunier, L Camoin-Jau, M Tuffigo, ... Frontiers in Medicine 7, 599626, 2020 | 19 | 2020 |
| Discontinuous epitopes on the C2 domain of coagulation Factor VIII mapped by computer‐designed synthetic peptides A Lebreton, V Moreau, P Lapalud, C Cayzac, S André, C Nguyen, ... British journal of haematology 155 (4), 487-497, 2011 | 17 | 2011 |
| Favorable outcome of rivaroxaban-associated intracerebral hemorrhage reversed by 4-factor prothrombin complex concentrate: impact on thrombin generation S Kauffmann, R Chabanne, A Coste, F Longeras, T Sinegre, J Schmidt, ... A&A Practice 4 (11), 151-154, 2015 | 15 | 2015 |
| Management of rare inherited bleeding disorders: proposals of the French Reference Centre on Haemophilia and Rare Coagulation Disorders M Trossaert, V Chamouard, C Biron‐Andreani, A Casini, ... European Journal of Haematology 110 (6), 584-601, 2023 | 12 | 2023 |
Alessandro CasiniUniversity Hospitals of Geneva在 hcuge.ch 的电子邮件经过验证
